Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1995-06-06
1997-04-08
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424426, 424471, 424472, 424473, 514960, 514975, A61K 910, A61K 924, A61K 926, A61K 4734
Patent
active
056185600
ABSTRACT:
Articles for the controlled delivery of an active substance into an aqueous phase by erosion of surfaces of the articles at a substantially constant and pH-independent rate, the articles comprising a matrix of crystalline polyethylene glycol polymer and a non-ionic emulsifier having an HLB value in the range of from about 4 to about 16 dispersed in the matrix in an amount of between about 2% and 50% by weight of the crystalline polyethylene glycol polymer and the emulsifier, the emulsifier having at least one domain which enables the emulsifier to become emulsified in the melted crystalline polyethylene glycol polymer and being selected from the group consisting of a fatty acid ester and a fatty alcohol ether, the active substance being dispersed in the matrix or located in geometrically well-defined zones within the crystalline PEG phase or dispersed in the emulsifier and, optionally, a filler. The non-ionic emulsifier or the active substance substantially eliminates water diffusion in the interface between the polymer crystals to thereby act as a repair medium and maintain substantially the geometric shape of the articles and, thus, maintain substantially constant the surface area exposed to solution.
REFERENCES:
patent: 3594469 (1971-07-01), Whitehead et al.
patent: 3634584 (1972-01-01), Pole
patent: 4053581 (1977-10-01), Chien et al.
patent: 4230686 (1980-10-01), Schopflin et al.
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4351825 (1982-09-01), Sothmann et al.
patent: 4368185 (1983-01-01), Mizuno et al.
patent: 4629621 (1986-12-01), Snipes
patent: 4690824 (1987-09-01), Powell et al.
patent: 4744976 (1988-05-01), Snipes et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4774074 (1988-09-01), Snipes
patent: 4784855 (1988-11-01), Yamashita et al.
patent: 4806337 (1989-02-01), Snipes et al.
patent: 5244668 (1993-09-01), Snipes
Tuda, et al. Basic Course for Medical Development XI--A Method of Drug Preparation (1st. vol), 1971 pp. 134-139.
Huttenrauch, R., "Fortschritte and Tendenzen in der Entwicklung neuer Arzneiformen", Die Pharmazie, 33: 481-499 (1978) (No Translation).
Hsieh, et al, "Enhanced release of drugs from silicone elastomers (II): Induction of Swelling and Changes in Microstructure", Drug Develop. Industr. Pharm., 11: 1411-1432 (1985).
Carelli, et al, "Factors in zero-order release of clonidine hydrochloride from monolithic poly-dimethyl silozane matrices", Int.J.Pharm, 35:21-8, 1987 (Chem.Abs., 106:14389j (1987).
Bar-Shalom Daniel
Kindt-Larsen Ture
BM Research A/S
Webman Edward J.
LandOfFree
Controlled release erodible composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release erodible composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release erodible composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396561